Showing 2141-2150 of 4064 results for "".
A Treatment for Schizophrenia in Adults
https://reachmd.com/industry-feature/psychiatry-and-mental-health/treatment-schizophrenia-adults/7535/Please see Important Safety Information, including Boxed Warning.Host Dr. Matt Birnholz and guest expert, Dr. Roger McIntyre...Saving Grandmother’s Brain: Therapeutic Options for Maintaining Midlife Mood, Mind, and Memory
https://reachmd.com/programs/clinicians-roundtable/saving-grandmothers-brain-therapeutic-options-maintaining-midlife-mood-mind-and-memory/7512/Studies in the field of anthropology have shown that having a healthy grandmother plays a critically positive role in family cohesion. But the wholistic, personalized health needs of women in their elder years are not always recognized. This care disparity is all the more prominent in general OB/GYNFive Days at Memorial: Life and Death in a Storm-Ravaged Hospital, Part 1
https://reachmd.com/programs/book-club/five-days-at-memorial-life-and-death-in-a-storm-ravaged-hospital-part-1/6929/In her book, Five Days at Memorial, physician and reporter Sheri Fink reconstructs 5 days at Memorial Medical Center and draws the reader into the lives of those who struggled mightily to survive and to maintain life amid chaos. Drawing from a culmination of six years of reporting, Dr. Fink unspoolsThe Scientific Pursuit of More Precise Care
https://reachmd.com/programs/heart-matters/the-scientific-pursuit-of-more-precise-care/4790/Patient-centered care is a hot topic in health care these days, though usually when we think of patient-centeredness, our thinking tilts toward aspects of policymaking or system delivery. Host Dr. Janet Wright takes a look at the science side of patient-centered care — the more precise tailoring ofFinerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
https://reachmd.com/clinical-practice/nephrology/finerenone-vs-placebo-in-type-1-diabetes-and-ckd-updates-from-the-phase-3-fine-one-trial-from-the-kidney-meeting-2025-in-houston/36517/Are you current with the findings from the phase 3 FINE-ONE trial? Join Dr. Heerspink as he summarizes what you need to know about this study.Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
https://reachmd.com/programs/cme/safety-clinical-integration-and-the-emerging-fifth-pillar-in-hf-practice/54635/Drs. Bauersachs, Butler & Lam discuss persistent residual risk in HFrEF, the use of sGC stimulators to reduce risk, and supporting evidence for this approach.Implications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?
https://reachmd.com/clinical-practice/nephrology/implications-of-the-fine-one-trial-how-might-recently-presented-data-from-the-2025-kidney-meeting-influence-the-current-treatment-paradigm-for-type-1-diabetes-and-ckd/39958/Dr. Pratley evaluates recent data from the FINE-ONE trial and explains the relevance of these findings to clinical practice.Addressing Skin Laxity with Physician-Tested Serum in GLP-1 Patients
https://reachmd.com/ma-issues-index/september-october-2025/addressing-skin-laxity-with-physician-tested-serum-in-glp-1-patients/39309/Postbiotics and Microneedling: An Emerging Approach for Acne Relief
https://reachmd.com/programs/clinicians-roundtable/postbiotics-and-microneedling-an-emerging-approach-for-acne-relief/30053/A recent study found that combining probiotics and microneedling shows potential as an alternative acne treatment. Read more about the results.MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
https://reachmd.com/programs/neurofrontiers/ms-research-using-epigenetic-clocks-and-biomarkers-to-assess-biological-aging/18038/Find out how biomarkers like p16 and the epigenetic clock can be used to assess biological aging in patients with multiple sclerosis.